These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17936955)

  • 1. [Results of ARMYDA-ACS trial show good outcome of 80 mg atorvastatin pretreatment in patients with acute coronary syndromes undergoing early percutaneous coronary intervention].
    Michałek A
    Kardiol Pol; 2007 Jul; 65(7):851-2; discussion 853-4. PubMed ID: 17936955
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
    Patti G; Chello M; Gatto L; Alfano G; Miglionico M; Covino E; Di Sciascio G
    J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):795-800. PubMed ID: 20613550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
    Patti G; Pasceri V; Colonna G; Miglionico M; Fischetti D; Sardella G; Montinaro A; Di Sciascio G
    J Am Coll Cardiol; 2007 Mar; 49(12):1272-8. PubMed ID: 17394957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose atorvastatin in acute coronary and cerebrovascular syndromes.
    Lavie CJ; Milani RV
    JACC Cardiovasc Interv; 2010 Mar; 3(3):340-2. PubMed ID: 20298995
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefit and tolerability of the coadministration of ezetimibe and atorvastatin in acute coronary syndrome patients.
    Hamdan R; Hajj F; Kadry Z; Kassab R; Salame E; Aboujaoude S; Azar R; Badaoui G
    J Med Liban; 2011; 59(2):65-9. PubMed ID: 21834489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].
    Su JZ; Xue Y; Cai WQ; Huang QY; Chai DJ; Chen GL; Wang FB; Chen XP; Zhang DS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Sep; 39(9):807-11. PubMed ID: 22321227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.
    Gómez-Gerique JA; Casciano R; Stern L; Rejas J
    Eur J Health Econ; 2004 Oct; 5(3):278-84. PubMed ID: 15714350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and rationale of a study in Asia of atorvastatin pretreatment in patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndromes.
    Ge J; Kim YJ; Jang YS; Zhu J; Marschner IC; Lam W
    J Cardiol; 2010 May; 55(3):303-8. PubMed ID: 20350523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
    Patti G; Pasceri V; Nusca A; Di Sciascio G
    Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-marketing study of clinical experience of atorvastatin 80 mg vs 40 mg in Indian patients with acute coronary syndrome- a randomized, multi-centre study (CURE-ACS).
    Kaul U; Varma J; Kahali D; Hiremath MS; Dani S; Dalal J; Ramchandran P; Rane R; Barkate H; Jindal C
    J Assoc Physicians India; 2013 Feb; 61(2):97-101. PubMed ID: 24471247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of atorvastatin on hs-CRP in acute coronary syndrome.
    Gupta A; Badyal DK; Khosla PP; Uppal B; Jaison TM; Chopra S
    Br J Clin Pharmacol; 2008 Sep; 66(3):411-3. PubMed ID: 18637893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study.
    Patti G; Tomai F; Melfi R; Ricottini E; Macrì M; Sedati P; Giardina A; Aurigemma C; Leporace M; D'Ambrosio A; Di Sciascio G
    J Am Coll Cardiol; 2013 Apr; 61(13):1379-87. PubMed ID: 23490041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
    Di Sciascio G; Patti G; Pasceri V; Gaspardone A; Colonna G; Montinaro A
    J Am Coll Cardiol; 2009 Aug; 54(6):558-65. PubMed ID: 19643320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins in acute coronary syndromes and genetic insight.
    Superko HR; Momary K; King S
    J Am Coll Cardiol; 2010 Mar; 55(12):1281-1282. PubMed ID: 20298941
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value.
    Lewandowski M; Kornacewicz-Jach Z; Millo B; Zielonka J; Czechowska M; Kaliszczak R; Płońska E; Goracy J; Kaźmierczak J; Naruszewicz M
    Cardiol J; 2008; 15(4):357-64. PubMed ID: 18698545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost-effectiveness of atorvastatin in the early treatment of acute coronary syndromes in Germany based on the MIRACL study].
    Lange AP; Szucs TD
    Med Klin (Munich); 2004 Sep; 99(9):500-5. PubMed ID: 15372179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial).
    Wojakowski W; Pyrlik A; Król M; Buszman P; Ochała A; Milewski K; Smolka G; Kawecki D; Rudnik A; Pawłowski T; Jadczyk T; Wyderka R; Cybulski W; Dworowy S; Tendera M
    Minerva Cardioangiol; 2013 Jun; 61(3):301-11. PubMed ID: 23681133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    van der Harst P; Voors AA; van Veldhuisen DJ
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15306676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.